Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of April 15, 2025, CSL (CSL.AX) has a market cap of $74.79 billion USD. According to our data, CSL is ranked No.240 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Apr 15, 2025 | $74.79 B |
-13.55%
|
| Dec 31, 2024 | $86.51 B |
-0.43%
|
| Dec 29, 2023 | $86.89 B |
0.91%
|
| Dec 30, 2022 | $86.11 B |
0.13%
|
| Dec 31, 2021 | $86.00 B |
3.72%
|
| Dec 31, 2020 | $82.91 B |
3.72%
|
| Dec 31, 2019 | $79.94 B |
50.75%
|
| Dec 31, 2018 | $53.02 B |
32.64%
|
| Dec 29, 2017 | $39.98 B |
42.66%
|
| Dec 30, 2016 | $28.02 B |
-3.02%
|
| Dec 31, 2015 | $28.90 B |
23.71%
|
| Dec 31, 2014 | $23.36 B |
27.86%
|
| Dec 31, 2013 | $18.27 B |
30.10%
|
| Dec 31, 2012 | $14.04 B |
72.12%
|
| Dec 30, 2011 | $8.16 B |
-9.44%
|
| Dec 31, 2010 | $9.01 B |
14.38%
|
| Dec 31, 2009 | $7.88 B |
-1.61%
|
| Dec 31, 2008 | $8.00 B |
-6.14%
|
| Dec 31, 2007 | $8.53 B |
68.81%
|
| Dec 29, 2006 | $5.05 B |
55.88%
|
| Dec 30, 2005 | $3.24 B |
47.30%
|
| Dec 31, 2004 | $2.20 B |
66.28%
|
| Dec 31, 2003 | $1.32 B |
-15.65%
|
| Dec 31, 2002 | $1.57 B |
-57.52%
|
| Dec 31, 2001 | $3.69 B |
32.65%
|
| Dec 29, 2000 | $2.78 B |
79.86%
|
| Dec 31, 1999 | $1.55 B |
58.62%
|
| Dec 31, 1998 | $0.98 B |
48.33%
|
| Dec 31, 1997 | $0.66 B |
64.57%
|
| Dec 31, 1996 | $0.40 B |
52.32%
|
| Dec 29, 1995 | $0.26 B |
71.40%
|
| Dec 30, 1994 | $0.15 B |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 Sanofi
SNY
|
$123.58 B |
-0.002 M
|
France
|
 Pfizer
PFE
|
$127.27 B |
-0.003 M
|
USA
|
 Novartis
NVS
|
$217.12 B |
0.003 M
|
Switzerland
|
 AstraZeneca
AZN
|
$210.42 B |
-0.005 M
|
UK
|
 GlaxoSmithKline
GSK
|
$72.33 B |
-0.002 M
|
UK
|
 Johnson & Johnson
JNJ
|
$370.20 B |
0.003 M
|
USA
|
 Merck
MRK
|
$197.26 B |
0.003 M
|
USA
|
 Bristol-Myers Squibb
BMY
|
$101.74 B |
-0.001 M
|
USA
|
 Amgen
AMGN
|
$158.77 B |
0.132 B
|
USA
|
 Eli Lilly
LLY
|
$679.94 B |
-0.022 M
|
USA
|
 AbbVie
ABBV
|
$312.76 B |
-0.013 M
|
USA
|
 Biogen
BIIB
|
$17.12 B |
0.000 M
|
USA
|
 Regeneron Pharmaceuticals
REGN
|
$60.99 B |
1.014 B
|
USA
|
| Market Cap | = | CSL.AX Stock Price | * | CSL.AX Shares Outstanding |
| = | $154.45 | * | 0.48 B | |
| = | $74.79 B |